| Name | Title | Contact Details |
|---|
Allos Therapeutics, Inc. is a biopharmaceutical company that is focused on developing and commercializing small molecule drugs for the treatment of cancer. The CompanyÍs lead product candidate, pralatrexate (PDX) an antifolate, is in Phase II trial in
DMC is leading the low cost sustainable transformation of multiple product markets.
RareCyte is a company focused on characterizing and isolating rare cells from blood.
Main OfficeReaction Design is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Verseau is creating a new class of therapeutics, macrophage checkpoint modulators, to benefit patients with cancer, immune and inflammatory diseases.